Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)

NCT06193928 · clinicaltrials.gov ↗

RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Alagille Syndrome
Progressive Familial Intrahepatic Cholestasis

Interventions

DRUG: Livmarli
DRUG: Livmarli

Sponsor

Mirum Pharmaceuticals, Inc.